Resultados de la búsqueda

Garcia-Pavia P, Kristen AV, Drachman B, Carlsson M, Amass L, Maurer MS; THAOS investigators. Understanding how long people with transthyretin amyloid cardiomyopathy (ATTR-CM) live when they take tafamidis as part of their regular healthcare: a plain language summary. Future Cardiol (2025) 21:433-445

Andrade JG, Jackson LR 2nd, Diaz JC, Chung M, Hurwitz J, Morillo CA, Lip GYH, Lopez-Cabanillas N. Atrial fibrillation in the Americas. Lancet Reg Health Am (2025) 47:101110

Jurcut R, Barriales-Villa R, Biagini E, Garcia-Pavia P, Olivotto I, Protonotarios A, Arbustini E, Mogensen J, Elliott P, Arbelo E, Pablo Kaski J; Members of the Task Force for the 2023 ESC Guidelines for the management of cardiomyopathies. Key priorities for the implementation of the 2023 ESC Guidelines for the Management of Cardiomyopathies in low resource settings. Eur Heart J Qual Care Clin Outcomes (2025) Mar 31 [Epub ahead of print]

Forte-Castro A, Pérez JM, Domene MA, Ovejero-Paredes K, Filice M, Fernández I. Design and characterization of a multifunctional Ag/Ag(I)-coated olive stone material for enhanced preservation and antibacterial protection. Food Packag Shelf Life (2025) 49

Cabrera-Alarcón JL, Rosa-Moreno M, Sánchez-García L, Hernansanz-Agustín P, Jiménez-Gómez MC, Martínez F, Sánchez-Cabo F, Enríquez JA. Structural diversity and evolutionary constraints of oxidative phosphorylation Cell Genomics (2025) 5:100945
Link to the full text in Repisalud

Nogales P, Velasco C, González-Cintado L, Sharysh D, Mota-Cobián A, Izquierdo-Serrano R, Torroja C, Del Rio-Aledo D, Morales-Cano D, Mota RA, Benguría A, Dopazo A, Sánchez-Cabo F, Vázquez J, España S, Carramolino L, Mateo J, Bentzon JF. Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET. Sci Transl Med (2025) 17:eado6467
Link to the full text in Repisalud

Ferrera C, Espejo-Paeres C, Jiménez-Quevedo P, Prado ND, Nombela-Franco L, Fernández-Pérez C, Noriega FJ, Rosillo N, Gonzalo N, Fernández-Jiménez R, Núñez-Gil IJ, Bernal JL, Pérez P, Escaned J, Fernández-Ortiz A, Elola FJ, Viana-Tejedor A. Treatment of severe aortic stenosis and cardiogenic shock: outcomes of TAVR vs SAVR and medical therapy. HELLENIC JOURNAL OF CARDIOLOGY (2025) S1109-9666:00189-7.

Mora-Ayestarán N, Gil-Llopis C, González-Maniega C, Piovano MV, Águila-Gordo D, Briceño A, González-Vioque E, Domínguez F, González-López E, Garcia-Pavia P. Impact of Genetic Testing Family Screening in Hereditary Transthyretin Amyloidosis. JACC CardioOncol (2025) 7:763-766

Salvadó G, Janelidze S, Bali D, Dolado AO, Therriault J, Brum WS, Pichet Binette A, Stomrud E, Mattsson-Carlgren N, Palmqvist S, Coomans EM, Teunissen CE, van der Flier WM, Rahmouni N, Benzinger TLS, Gispert JD, Blennow K, Doré V, Feizpour A, Rowe CC, Alcolea D, Fortea J, Villeneuve S, Johnson SC, Rosa-Neto P, Petersen RC, Jack CR Jr, Schindler SE, Suárez-Calvet M, Ossenkoppele R, Hansson O; ADNI, ALFA, and PREVENT-AD Study Groups. lasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurol (2025) :e253217

Crespo-Leiro MG, Hanna M, Damy T, Delgado D, Ebede B, Marino V, Wang R, Maurer MS, Garcia-Pavia P, Drachman BM. arly Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy. JACC Adv (2025) 4:102122